Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGM:PAHC
NasdaqGM:PAHCPharmaceuticals

Assessing Phibro Animal Health (PAHC) Valuation After Strong Q2 Results And Higher 2026 Earnings Guidance

Phibro Animal Health (PAHC) is back in focus after reporting second quarter results that show much higher sales and net income versus a year earlier, along with updated 2026 earnings guidance and a reaffirmed dividend. See our latest analysis for Phibro Animal Health. The recent guidance update and stronger quarterly results have come after a sharp run in the shares, with a 30 day share price return of 31.47% and a year to date share price return of 39.01%. Longer term momentum is reflected...
NasdaqCM:MARA
NasdaqCM:MARASoftware

French Review Of Xion Deal Tests MARA Holdings’ European Expansion Story

French authorities have paused MARA Holdings’ planned acquisition of EDF’s Xion data center, citing national security and sovereignty concerns. The review directly affects MARA Holdings’ push into European data infrastructure and broader computing capacity. The decision introduces additional regulatory risk around energy access and international expansion for NasdaqCM:MARA. MARA Holdings, traded on NasdaqCM:MARA, last closed at $8.06, with the share price reflecting a 10.9% decline over the...
NYSE:EG
NYSE:EGInsurance

Everest Group (EG) Valuation Check After Stronger Earnings And Ongoing Share Buybacks

Everest Group (EG) is back in focus after reporting fourth quarter and full year 2025 results that showed higher net income along with active share repurchases, a combination that has drawn fresh attention to the stock. See our latest analysis for Everest Group. Despite the stronger earnings picture and ongoing buybacks, Everest Group’s share price has eased recently, with a 30 day share price return of a 3.32% decline and a 1 year total shareholder return of a 1.09% decline. This suggests...
NasdaqGS:SVRA
NasdaqGS:SVRABiotechs

A Look At Savara (SVRA) Valuation After Expanded Hercules Funding Linked To MOLBREEVI Approval

Savara (SVRA) amended its loan agreement with Hercules Capital, giving it access to up to an additional $75 million if the FDA approves MOLBREEVI, its investigational therapy for autoimmune pulmonary alveolar proteinosis. See our latest analysis for Savara. Against the backdrop of the Hercules and royalty funding agreements, Savara’s 90 day share price return of 26.94% and 1 year total shareholder return of 90.18% indicate that momentum has been building despite recent shorter term share...
NasdaqCM:WULF
NasdaqCM:WULFSoftware

Google Deepens TeraWulf Ties As Bitcoin Miner Pivots To AI Infrastructure

Google has increased its stake in TeraWulf (NasdaqCM:WULF) to 14%, taking a larger ownership position in the company. As part of the move, Google is providing substantial backstop funding to support the expansion of TeraWulf's Lake Mariner data center. The funding is tied to TeraWulf's shift from a pure bitcoin mining focus toward building AI focused data center infrastructure. TeraWulf, known primarily as a bitcoin miner, is repositioning itself as a provider of power intensive...
NYSE:KEX
NYSE:KEXShipping

A Look At Kirby (KEX) Valuation After Strong Q4 Results And Ongoing Share Buybacks

Kirby (KEX) is back in focus after reporting fourth quarter revenue of US$851.78 million and net income of US$91.81 million, alongside an update on its long running share repurchase program. See our latest analysis for Kirby. The latest earnings and ongoing buybacks come after a strong 90 day share price return of 8.98% and a 1 year total shareholder return of 11.90%, with 3 and 5 year total shareholder returns of 64.86% and 97.51%. This suggests longer term momentum has been stronger than...
NasdaqGS:OKTA
NasdaqGS:OKTAIT

Okta (OKTA) Valuation Check As PGA Of America Partnership Highlights Its Identity And AI Security Role

Okta (OKTA) shares are back in focus after the company expanded its relationship with the PGA of America, a move that ties its identity platform directly to fan and member digital experiences. See our latest analysis for Okta. Those PGA and AI security headlines arrive at a time when Okta’s short term share price performance has been mixed, with a 30 day share price return of a 4.39% decline and a 90 day share price return of a 3.04% gain. Over a longer horizon, the 1 year total shareholder...
TSX:GAU
TSX:GAUMetals and Mining

High-Grade Abore Underground Drilling Results Could Be A Game Changer For Galiano Gold (TSX:GAU)

Galiano Gold Inc. reported the latest results from its 2025 Abore drilling program at the Asanko Gold Mine in Ghana, confirming multiple high-grade gold intercepts and new mineralization up to 200 meters below previous holes, with these data feeding into a maiden underground Mineral Resource estimate now expected in February 2026. The strong intercepts, including 14.2 grams per tonne of gold over 15 meters from hole ABDD25-431, underline Abore’s underground potential and increase investor...
NYSE:DOCS
NYSE:DOCSHealthcare Services

Assessing Doximity (DOCS) Valuation After Earnings Beat AI Tool Adoption And New Buyback Program

Doximity (DOCS) is back in focus after its latest quarter topped internal guidance. Management highlighted growing use of its AI tools by clinicians, and the company paired cautious revenue guidance with a fresh share repurchase authorization. See our latest analysis for Doximity. Despite the better than expected quarter and new AI tools, the share price has been under pressure, with a 30 day share price return of 37.2% and a 1 year total shareholder return of 66.9%, suggesting sentiment has...
NYSE:DOW
NYSE:DOWChemicals

Does Dow’s (DOW) Share Buyback Strategy Justify Its Shift From Profit to Loss?

Dow Inc. has reported past fourth-quarter 2025 sales of US$9,460 million, down from US$10,405 million a year earlier, and moved from a small prior-year loss to a much larger net loss of US$1,543 million, while completing a share repurchase of 38,539,462 shares for US$2,069.24 million under its April 2022 program. For full-year 2025, Dow’s sales fell to US$39.97 billion from US$42.96 billion and it shifted from prior-year net income of US$1,116 million to a net loss of US$2,623 million,...
ENXTPA:DBV
ENXTPA:DBVBiotechs

Is DBV Technologies (ENXTPA:DBV) Pricing In Too Much Optimism After Its 1‑Year Surge

If you are wondering whether DBV Technologies at €3.87 is starting to look interesting or already pricing in a lot of optimism, you are not alone. The share price data shows returns of 1.8% over the past week, 27.9% over the past month, 18.5% year to date, 386.8% over the past year and 53.6% over three years, while the five year return sits at a 59.8% decline. Recent news around DBV Technologies has focused on its progress and ongoing developments in allergy treatments, along with market...
NYSE:LII
NYSE:LIIBuilding

Lennox Buybacks Retire 40% Of Shares And Shape Growth Outlook

Lennox International (NYSE:LII) has completed a new share repurchase tranche, buying back nearly 0.85% of its shares in the most recent quarter. This brings total buybacks under the long running program to almost 40% of the company’s outstanding shares. The latest activity reflects an ongoing focus on returning capital to shareholders through repurchases. For investors watching NYSE:LII, the scale of the buyback program is now a core part of the story. The stock closed at $529.29, with...
NasdaqGS:PGNY
NasdaqGS:PGNYHealthcare

Is Progyny (PGNY) Mispriced After Recent Share Price Weakness And DCF Upside Potential

If you are wondering whether Progyny's current share price reflects its true worth, this article walks through what the numbers are really saying about the stock. After closing at US$21.65, the shares have seen recent pressure, with returns of a 10.6% decline over 7 days, 19.8% decline over 30 days, 15.9% decline year to date, 3.1% decline over 1 year, 32.9% decline over 3 years, and 57.0% decline over 5 years. These moves come against a backdrop of ongoing interest in fertility benefits and...
NYSE:NOC
NYSE:NOCAerospace & Defense

Northrop Grumman Weighs Ukraine Penalties Against New Japan Contract Upside

Northrop Grumman (NYSE:NOC) is facing U.S. Army penalties linked to significant delays in artillery ammunition deliveries destined for Ukraine. Separately, the company secured a large contract to provide advanced aircraft components to Japan, expanding its international defense presence. For a company like Northrop Grumman, which sits at the center of U.S. and allied defense procurement, this mix of pressure and opportunity is important. The potential U.S. Army penalties highlight...
TSX:DPM
TSX:DPMMetals and Mining

DPM Metals (TSX:DPM) Is Up 12.0% After Extending Chelopech Mine Life To 2036 - Has The Bull Case Changed?

DPM Metals Inc. recently updated the Mineral Resource and Mineral Reserve estimate and life-of-mine plan for its Chelopech mine in Bulgaria, adding 6.9 Mt of reserves and extending mine life to 2036 with an average of about 160,000 GEO per year. The inclusion of the Sharlo Dere prospect in reserves and the high-grade WZD discovery, alongside progress on nearby concessions, highlights a broader growth pipeline around Chelopech. We will examine how the extended Chelopech mine life and new...